Carl Dmuchowski Selected Research

ASP9853

3/2016

ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl Dmuchowski Research Topics

Disease

3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 06/2015
1	Arthralgia (Joint Pain) 01/2020
1	Fatigue 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Pain (Aches) 06/2017
1	Lung Neoplasms (Lung Cancer) 03/2016
1	Neoplasms (Cancer) 03/2016
1	Neutropenia 03/2016
1	Disease Progression 06/2015

Drug/Important Bio-Agent (IBA)

3	enzalutamideIBA 01/2020 - 06/2015
3	Docetaxel (Taxotere)FDA Link 06/2017 - 06/2015
2	abirateroneIBA 01/2020 - 06/2015
1	AndrogensIBA 01/2020
1	Alkaline PhosphataseIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Abiraterone AcetateIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 06/2017
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2016
1	taxaneIBA 03/2016
1	ASP9853IBA 03/2016
1	cabazitaxel FDA Link 06/2015

Therapy/Procedure

3	Castration 01/2020 - 06/2015
1	Drug Therapy (Chemotherapy) 06/2017
1	Therapeutics 03/2016